126 related articles for article (PubMed ID: 9076770)
1. 99Tcm-LL1: a potential new bone marrow imaging agent.
Juweid M; Dunn RM; Sharkey RM; Rubin AD; Hansen HJ; Goldenberg DM
Nucl Med Commun; 1997 Feb; 18(2):142-8. PubMed ID: 9076770
[TBL] [Abstract][Full Text] [Related]
2. Assessment of functional liver reserve: old and new in 99mTc-sulfur colloid scintigraphy.
Matesan MM; Bowen SR; Chapman TR; Miyaoka RS; Velez JW; Wanner MF; Nyflot MJ; Apisarnthanarax S; Vesselle HJ
Nucl Med Commun; 2017 Jul; 38(7):577-586. PubMed ID: 28591006
[TBL] [Abstract][Full Text] [Related]
3. Double-tracer dosimetry of organs in assessment of bone marrow involvement by two monoclonal antibodies.
Korppi-Tommola ET; Kairemo KJ; Jekunen AP; Niskanen EO; Savolainen SE
Acta Oncol; 1996; 35(3):357-65. PubMed ID: 8679267
[TBL] [Abstract][Full Text] [Related]
4. Factors influencing the pharmacokinetics, dosimetry, and diagnostic accuracy of radioimmunodetection and radioimmunotherapy of carcinoembryonic antigen-expressing tumors.
Behr TM; Sharkey RM; Juweid MI; Dunn RM; Ying Z; Zhang CH; Siegel JA; Gold DV; Goldenberg DM
Cancer Res; 1996 Apr; 56(8):1805-16. PubMed ID: 8620497
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow immunoscintigraphy for the detection of skeletal metastases in patients with breast cancer.
Lacić M; Bokulić T; Lukac J; Kovacić K; Baum RP; Kusić Z
Nucl Med Commun; 1999 Feb; 20(2):135-43. PubMed ID: 10088162
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow scintigraphy with 99m Tc labelled monoclonal anti-NCA 90 Fab' fragment: a feasibility study and comparison of bone marrow uptake with 99m Tc labelled monoclonal anti-NCA 95 antigranulocyte antibody.
Ivancevic V; Huic D; Wolter A; Munz DL
Nucl Med Commun; 2002 Mar; 23(3):249-55. PubMed ID: 11891483
[TBL] [Abstract][Full Text] [Related]
7. [Bone marrow scintigraphy. Principles, clinical results and indications].
Munz DL
Radiologe; 1992 Oct; 32(10):485-94. PubMed ID: 1438717
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow immunoscintigraphy using technetium-99m anti-granulocyte antibody in multiple myeloma.
Sohn SK; Ahn BC; Lee SW; Kim DH; Chun KA; Kim JG; Park SH; Song HS; Lee B; Lee J
Eur J Nucl Med Mol Imaging; 2002 May; 29(5):591-6. PubMed ID: 11976796
[TBL] [Abstract][Full Text] [Related]
9. 99mTc-labelled rituximab, a new non-Hodgkin's lymphoma imaging agent: first clinical experience.
Gmeiner Stopar T; Fettich J; Zver S; Mlinaric-Rascan I; Hojker S; Socan A; Peitl PK; Mather S
Nucl Med Commun; 2008 Dec; 29(12):1059-65. PubMed ID: 18987526
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow imaging of bone marrow transplanted multiple myeloma patients.
Agren B; Rudberg U; Måre K; Aspelin P
Clin Nucl Med; 1997 Feb; 22(2):80-92. PubMed ID: 9031764
[TBL] [Abstract][Full Text] [Related]
11. Lymphoma imaging with a new technetium-99m labelled antibody, LL2.
Murthy S; Sharkey RM; Goldenberg DM; Lee RE; Pinsky CM; Hansen HJ; Burger K; Swayne LC
Eur J Nucl Med; 1992; 19(6):394-401. PubMed ID: 1618230
[TBL] [Abstract][Full Text] [Related]
12. Quantitative evaluation of four 99Tcm colloids for bone marrow scintigraphy using single photon emission computed tomography.
Kalin B; Axelsson B; Jacobsson H
Nucl Med Commun; 1991 Feb; 12(2):135-45. PubMed ID: 2002961
[TBL] [Abstract][Full Text] [Related]
13. Radioimmunodetection of non-small cell lung cancer using technetium-99m-anticarcinoembryonic antigen IMMU-4 Fab' fragment. Preliminary results.
Kramer EL; Noz ME; Liebes L; Murthy S; Tiu S; Goldenberg DM
Cancer; 1994 Feb; 73(3 Suppl):890-5. PubMed ID: 8306275
[TBL] [Abstract][Full Text] [Related]
14. 99Tcm-labelled chimeric human/mouse anti-granulocyte antibody bone marrow scintigraphy: a preliminary clinical study.
Higuchi T; Inoue T; Sarwar M; Oriuchi N; Karasawa M; Naruse T; Yamanaka H; Watanabe T; Chung JK; Endo K
Nucl Med Commun; 1998 May; 19(5):463-74. PubMed ID: 9853336
[TBL] [Abstract][Full Text] [Related]
15. Distribution of 99Tcm-sulphur colloid during granulocyte colony-stimulating factor administration in autologous bone marrow transplantation.
Berlangieri SU; Peters WP; Coleman RE
Nucl Med Commun; 1993 Oct; 14(10):896-901. PubMed ID: 7694213
[TBL] [Abstract][Full Text] [Related]
16. Initial clinical results with technetium-99m-labeled LL2 monoclonal antibody fragment in the radioimmunodetection of B-cell lymphomas.
Baum RP; Niesen A; Hertel A; Adams S; Kojouharoff G; Goldenberg DM; Hör G
Cancer; 1994 Feb; 73(3 Suppl):896-9. PubMed ID: 8306276
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow scintigraphy using technetium-99m antigranulocyte antibody in malignant lymphomas.
Krause T; Eisenmann N; Reinhardt M; Bathmann J; Altehoefer C; Finke J; Moser E
Ann Oncol; 1999 Jan; 10(1):79-85. PubMed ID: 10076726
[TBL] [Abstract][Full Text] [Related]
18. Improving bone marrow scintigraphy. A clinical and experimental study.
Kalin B
Acta Radiol Suppl; 1993; 385():1-24. PubMed ID: 8517188
[TBL] [Abstract][Full Text] [Related]
19. [Radionuclide study of the topography of hematopoiesis in erythremia].
Sakhibov IaD; Demidova AV
Ter Arkh; 1983; 55(8):63-8. PubMed ID: 6635959
[No Abstract] [Full Text] [Related]
20. Myelotoxicity and RBE of 211At-conjugated monoclonal antibodies compared with 99mTc-conjugated monoclonal antibodies and 60Co irradiation in nude mice.
Elgqvist J; Bernhardt P; Hultborn R; Jensen H; Karlsson B; Lindegren S; Warnhammar E; Jacobsson L
J Nucl Med; 2005 Mar; 46(3):464-71. PubMed ID: 15750160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
